Rain Oncology Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Rain Oncology Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2022.
  • Rain Oncology Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $54.1M, a 139% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $54.1M +$31.4M +139% Dec 31, 2022 10-K 2023-03-09
Q4 2021 $22.7M +$11.9M +110% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $10.8M Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.